ImmunoPrecise, Twist collaborate on novel therapeutics

By The Science Advisory Board staff writers

October 27, 2020 -- ImmunoPrecise subsidiary Talem Therapeutics and Twist Bioscience will collaborate on the creation of novel therapeutic molecules.

The early discovery collaboration will expand on Talem's diverse antibody pipeline by exploring ImmunoPrecise's technology in a wide range of oncology targets. ImmunoPrecise will contribute targets and the genetic sequences for lead antibodies against the selected targets. Twist Biopharma, a division of Twist Bioscience, will design synthetic antibody libraries based on the provided antibody repertoire sequences from immunized animals to discover optimized, humanized lead antibody candidates.

The companies aim to jointly advance the programs through proof-of-concept and preclinical development and will collaborate on any commercial opportunities generated by the efforts that may result in milestones or key preclinical, clinical, and commercial milestones as well as royalties for any antibodies resulting from the collaboration.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here